Author's replyBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7006.687a (Published 09 September 1995) Cite this as: BMJ 1995;311:687
- J E Compston
- Honorary consultant physician Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, Cambridge CB2 2QQ
EDITOR,—Catherine Nelson-Piercy and Michael de Swiet are right to draw attention to long term heparin treatment as another important, if relatively rare, risk factor for osteoporosis.
I welcome the opportunity to respond to Trevor Sheldon's views. Contrary to the implication in his letter, the conclusion that mass screening of perimenopausal women is not justifiable was reached by several experts1 2 before publication of the Effective Health Care bulletin, the conclusions of which were fortuitously correct although based on inadequate and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial